Thrombolytic Therapy versus Anticoagulant Therapy for Pulmonary Embolism:Evaluation of Therapeutic Efficacy

OBJECTIVE:To evaluate the clinical efficacy of thrombolytic therapy with Urokinase versus anticoagulant therapy with Low Molecular Heparin in the treatment of pulmonary embolism.METHODS:The clinical records of 41 patients with pulmonary embolism were collected and the efficacy of thrombolytic therapy versus anticoagulant therapy in dyspnea and chest pain and the blood gas indexes were analyzed retrospectively.RESULTS:Compared with the anticoagulant therapy group,the remission rates of dyspnea,chest pain,cough,hemoptisis and cyanosis were all significantly higher(P0.1)and the effective rate was also higher(P0.05)in the thrombolytic therapy group.CONCLUSION:The results suggest that the therapeutic efficacy of thrombolytic therapy with Urokinase is higher than that of anticoagulant therapy with Low Molecular Heparin in the treatment of pulmonary embolism.